| scholarly article | Q13442814 |
| P2093 | author name string | Diane Goere | |
| Loic Campion | |||
| Olivier Glehen | |||
| Frédéric Dumont | |||
| Marc Pocard | |||
| Hélène Senellart | |||
| Emilie Thibaudeau | |||
| Francois Pein | |||
| P2860 | cites work | Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. | Q51709594 |
| Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? | Q53213677 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis | Q79775363 | ||
| Global cancer statistics | Q22241238 | ||
| Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes | Q26768299 | ||
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. | Q27313250 | ||
| Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 | ||
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma | Q33400615 | ||
| Oxaliplatin: a review in the era of molecularly targeted therapy | Q34541434 | ||
| Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients | Q35110064 | ||
| Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. | Q35721069 | ||
| Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality | Q37498106 | ||
| Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients | Q37662806 | ||
| Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis | Q38456068 | ||
| Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study. | Q40112672 | ||
| Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center | Q40158108 | ||
| Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. | Q41146040 | ||
| Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study | Q41595425 | ||
| Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. | Q43064315 | ||
| Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 | ||
| Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR). | Q43516115 | ||
| Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors | Q43880060 | ||
| Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution | Q43910359 | ||
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
| Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. | Q44408342 | ||
| Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? | Q44522396 | ||
| Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). | Q46350650 | ||
| Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer | Q46742453 | ||
| Description of a novel approach for intraperitoneal drug delivery and the related device | Q50150981 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | oxaliplatin | Q422327 |
| peritoneal carcinomatosis | Q2071182 | ||
| phase I clinical trial | Q5452194 | ||
| P304 | page(s) | 20180120 | |
| P577 | publication date | 2018-09-15 | |
| P1476 | title | Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design | |
| P478 | volume | 3 |
| Q92255092 | Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) |
| Q91572974 | Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications |
| Q92764306 | Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework |
| Q92226266 | Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, pha |
| Q89493428 | Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway |
Search more.